Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 5/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 5/20 | 0.46 |
| ▸ | AKR1C2 | P52895 | 5/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5558739 | 0.90 | AKR1C3 (0.57) | AKR1C3AKR1C2PTGS2NPSR1LMNA | |
| SCHEMBL5559612 | 0.90 | PLA2G2A (0.49) | PLA2G2AAKR1C3AKR1C2PTGS2MAPT | |
| SCHEMBL6424911 | 0.88 | AKR1C3 (0.45) | PLA2G2AAKR1C3AKR1C2PTGS2NPSR1 | |
| SCHEMBL6424244 | 0.87 | PLA2G2A (0.44) | PLA2G2AAKR1C3AKR1C2PTGS2NPSR1 | |
| SCHEMBL6424277 | 0.86 | PTGS2 (0.46) | PLA2G2AAKR1C3AKR1C2PTGS2NPSR1 | |
| SCHEMBL5801149 | 0.86 | AKR1C3 (0.43) | AKR1C3AKR1C2PTGS2NPSR1LMNA | |
| SCHEMBL5559334 | 0.85 | AKR1C3 (0.44) | AKR1C3AKR1C2PTGS2NPSR1LMNA | |
| SCHEMBL5560684 | 0.85 | AKR1C3 (0.43) | AKR1C3AKR1C2PTGS2NPSR1SMN1; SMN2 | |
| SCHEMBL6426730 | 0.84 | PTGS2 (0.47) | PLA2G2AAKR1C3AKR1C2PTGS2NPSR1 | |
| SCHEMBL6465001 | 0.84 | AKR1C3 (0.46) | AKR1C3AKR1C2PTGS2NPSR1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | IRONWOOD PHARMACEUTICALS, INC. | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050234244-A1 | Synthesis of COX-2 and FAAH inhibitors | FAAH2, FAAH, PTGES2 | PLA2G2A 62/4885AKR1C3 577/4885AKR1C2 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.